{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:42:36Z","timestamp":1783485756775,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.4158\/ep11120.ed","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T21:22:22Z","timestamp":1310160142000},"page":"325-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The American Thyroid Association and American Association of Clinical Endocrinologists Guidelines for Hyperthyroidism and Other Causes of Thyrotoxicosis: An Appraisal"],"prefix":"10.1016","volume":"17","author":[{"given":"Gilbert H.","family":"Daniels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP11120.ED_bb0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4158\/EP.17.3.456","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical endocrinologists","volume":"17","author":"Bahn Chair","year":"2011","journal-title":"Endocr Pract"},{"key":"10.4158\/EP11120.ED_bb0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1530\/eje.0.1390584","article-title":"Guidelines for TSH-receptor antibody measurements in pregnancy: Results of an evidence-based symposium organized by the European Thyroid Association","volume":"139","author":"Laurberg","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP11120.ED_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"key":"10.4158\/EP11120.ED_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/thy.2008.0034","article-title":"The EUGOGO consensus statement on the management of Graves' orbitopathy: Equally applicable to North American clinicians and patients?","volume":"18","author":"Bahn","year":"2008","journal-title":"Thyroid"},{"key":"10.4158\/EP11120.ED_bb0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/thy.2010.1635","article-title":"Drugs affecting thyroid function","volume":"20","author":"Barbesino","year":"2010","journal-title":"Thyroid"},{"key":"10.4158\/EP11120.ED_bb0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/thy.2010.0300","article-title":"Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye","volume":"21","author":"Calvi","year":"2011","journal-title":"Thyroid"},{"key":"10.4158\/EP11120.ED_bb0040","first-page":"460","article-title":"Constitutively activating mutations of the thyrotropin receptor and thyroid disease","volume":"25","author":"F\u00fchrer","year":"1996","journal-title":"Eur J Med Res"},{"key":"10.4158\/EP11120.ED_bb0045","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/jc.2002-020921","article-title":"Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels","volume":"88","author":"Kim","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11120.ED_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/eje.0.1420231","article-title":"The effect of thyrotoxicosis on adrenocortical reserve","volume":"143","author":"Tsatsoulis","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP11120.ED_bb0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2265.1990.tb00483.x","article-title":"The effect of amiodarone on the control of hyperthyroidism by propylthiouracil","volume":"33","author":"Rajatanavin","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP11120.ED_bb0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.2005.02249.x","article-title":"The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism","volume":"62","author":"Tsai","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP11120.ED_bb0065","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jama.1947.02880270028006","article-title":"Thyrotoxic crisis; An analysis of thirty-six cases at the Massachusetts General Hospital during the past twenty-five years","volume":"134","author":"McArthur","year":"1947","journal-title":"JAMA"},{"key":"10.4158\/EP11120.ED_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis. Thyroid storm","volume":"22","author":"Burch","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP11120.ED_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1210\/jcem-57-2-250","article-title":"Use of adjunctive potassium iodine after radioactive iodine (131I) treatment of Graves' hyperthyroidism","volume":"57","author":"Ross","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11120.ED_bb0080","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4158\/EP.7.6.438","article-title":"Use of cold iodine in patients with Graves' disease: Observations from a clinical practice","volume":"7","author":"Hao","year":"2001","journal-title":"Endocr Pract"},{"key":"10.4158\/EP11120.ED_bb0085","first-page":"738","article-title":"Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy","volume":"75","author":"Momotani","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11120.ED_bb0090","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02169","article-title":"What is the evidence behind the evidence base? The premature death of block-replace antithyroid drug regimens for Graves' disease","volume":"154","author":"Razvi","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP11120.ED_bb0095","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00000658-198206000-00013","article-title":"Propranolol and thyroidectomy in the treatment of thyrotoxicosis","volume":"195","author":"Lee","year":"1982","journal-title":"Ann Surg"},{"key":"10.4158\/EP11120.ED_bb0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2265.2009.03745.x","article-title":"Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease","volume":"72","author":"Takata","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP11120.ED_bb0105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2010.03949.x","article-title":"Serum phosphate predicts temporary hypocalcaemia following thyroidectomy","volume":"74","author":"Sam","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP11120.ED_bb0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.amjsurg.2007.04.005","article-title":"Hyperpara-thyroidism after radioactive iodine therapy","volume":"194","author":"Cola\u00e7o","year":"2007","journal-title":"Am J Surg"},{"key":"10.4158\/EP11120.ED_bb0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring","volume":"150","author":"Tajiri","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP11120.ED_bb0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/eje.0.1340337","article-title":"Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: A randomized study","volume":"134","author":"Nolte Muller","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP11120.ED_bb0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2265.1996.00800.x","article-title":"A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism","volume":"45","author":"Page","year":"1996","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/056222L2107T1Q14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:53:05Z","timestamp":1761515585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20404458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":24,"aliases":["10.4158\/ep.17.3.325"],"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1530891X20404458"],"URL":"https:\/\/doi.org\/10.4158\/ep11120.ed","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The American Thyroid Association and American Association of Clinical Endocrinologists Guidelines for Hyperthyroidism and Other Causes of Thyrotoxicosis: An Appraisal","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP11120.ED","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}